Bacil Pharma Limited (BOM:524516)

Bacil Pharma Statistics

Total Valuation

Bacil Pharma has a market cap or net worth of INR 716.93 million. The enterprise value is 700.99 million.

Market Cap	716.93M
Enterprise Value	700.99M

Important Dates

The last earnings date was Friday, February 13, 2026.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Bacil Pharma has 14.35 million shares outstanding. The number of shares has increased by 116.22% in one year.

Current Share Class	14.35M
Shares Outstanding	14.35M
Shares Change (YoY)	+116.22%
Shares Change (QoQ)	-5.31%
Owned by Insiders (%)	70.55%
Owned by Institutions (%)	n/a
Float	4.15M

Valuation Ratios

The trailing PE ratio is 83.37.

PE Ratio	83.37
Forward PE	n/a
PS Ratio	130.85
PB Ratio	2.72
P/TBV Ratio	2.72
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	95.02
EV / Sales	127.94
EV / EBITDA	228.94
EV / EBIT	228.73
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	464.35

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	0.94%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	7.15%
Revenue Per Employee	2.74M
Profits Per Employee	3.69M
Employee Count	2
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Bacil Pharma has paid 2.30 million in taxes.

Income Tax	2.30M
Effective Tax Rate	23.73%

Stock Price Statistics

The stock price has increased by +31.03% in the last 52 weeks. The beta is 0.53, so Bacil Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.53
52-Week Price Change	+31.03%
50-Day Moving Average	42.01
200-Day Moving Average	40.49
Relative Strength Index (RSI)	62.87
Average Volume (20 Days)	13,687

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Bacil Pharma had revenue of INR 5.48 million and earned 7.38 million in profits. Earnings per share was 0.60.

Revenue	5.48M
Gross Profit	5.48M
Operating Income	3.06M
Pretax Income	9.67M
Net Income	7.38M
EBITDA	3.06M
EBIT	3.06M
Earnings Per Share (EPS)	0.60

Balance Sheet

The company has 15.94 million in cash and n/a in debt, with a net cash position of 15.94 million or 1.11 per share.

Cash & Cash Equivalents	15.94M
Total Debt	n/a
Net Cash	15.94M
Net Cash Per Share	1.11
Equity (Book Value)	263.50M
Book Value Per Share	19.09
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of 55.94% and 134.64%.

Gross Margin	100.00%
Operating Margin	55.94%
Pretax Margin	176.54%
Profit Margin	134.64%
EBITDA Margin	55.88%
EBIT Margin	55.94%
FCF Margin	n/a

Dividends & Yields

Bacil Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-116.22%
Shareholder Yield	-116.22%
Earnings Yield	1.03%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1